University of Pennsylvania (Penn)
The University of Pennsylvania (Penn), founded in 1740 by Benjamin Franklin, is a world-renowned Ivy League institution located in Philadelphia. Penn is dedicated to advancing knowledge, fostering innovation, and making a positive impact locally and globally. With a strong commitment to interdisciplinary research, academic excellence, and community engagement, Penn offers a diverse and inclusive environment for students, faculty, and staff. The university is recognized for its leadership in research, robust financial aid programs, and a tradition of civic involvement. Penn's strategic initiatives, such as Penn Forward, focus on reshaping education, research, and service to meet the challenges of a rapidly changing world. The university is also a leader in sustainability, aiming for carbon neutrality by 2042 and net-zero endowment emissions by 2050, and is home to a vibrant ecosystem of innovation, global engagement, and community partnership.
Industries
N/A
Nr. of Employees
small (1-50)
University of Pennsylvania (Penn)
Patents
Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor
2025-09-16 • US-12416016-B2
View DetailsRecombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
2025-09-16 • US-12416017-B2
View DetailsCompositions and methods for retrieving tumor-related antibodies and antigens
2025-09-09 • US-12410234-B2
View DetailsTreatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
2025-09-09 • US-12410232-B2
View Details
Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor
2025-09-16 • US-12416016-B2
View DetailsRecombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
2025-09-16 • US-12416017-B2
View DetailsCompositions and methods for retrieving tumor-related antibodies and antigens
2025-09-09 • US-12410234-B2
View DetailsTreatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
2025-09-09 • US-12410232-B2
View DetailsExpertise Areas
- Cell and gene therapy research and translation
- Translational medicine and clinical-trial enabling infrastructure
- Vaccine and infectious disease research
- Veterinary diagnostics and large-animal medicine
Key Technologies
- Patient-derived organoids
- Generative AI for molecular design
- Digital twin physiological simulation
- Machine learning for large-scale data analysis
Key People
President
Provost
Senior Vice President for Strategic Initiatives and John Morgan Professor
Senior Vice President and Chief Transformation Officer
President
Provost
Senior Vice President for Strategic Initiatives and John Morgan Professor
Senior Vice President and Chief Transformation Officer
News & Updates
Penn Dental Medicine at PHMC on Cedar integrates dental and medical care to reduce ER demands.
Penn Engineering research on lung tissue and fibrosis.
Penn Engineering develops a generative AI model for antibiotic discovery.
New methods to guide light for advanced technology applications.
Research on materials for future electronic devices.
AI-driven discovery of antibiotics in ancient microbes at Penn.
Penn Dental Medicine at PHMC on Cedar integrates dental and medical care to reduce ER demands.
Penn Engineering research on lung tissue and fibrosis.
Penn Engineering develops a generative AI model for antibiotic discovery.
New methods to guide light for advanced technology applications.
Research on materials for future electronic devices.
AI-driven discovery of antibiotics in ancient microbes at Penn.